Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Komarom – page 2

18 clinical trials in Komarom, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Komarom at a glance
18
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

18 trials in Komarom

Open in trial search
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Obesity+1

Not recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Obesity+1

Not recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Atrial fibrillation+2

Not recruiting
Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Other cities in Hungary

The busiest research cities in the country

All 70 cities in Hungary

Clinical research in Komarom

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking studies focusing on atherosclerotic cardiovascular disease prevention and innovative treatments for atrial fibrillation. Research aims to evaluate new therapeutic approaches for stroke prevention and cardiac event reduction.

  • Stroke Prevention Therapies
  • Cardiovascular Event Management
  • Blood Clot Prevention

Multiple trials comparing the effectiveness of novel medications against established treatments for heart conditions.

02 Metabolic Disorders

Clinical research examining treatments for Type 2 Diabetes Mellitus and mixed dyslipidemia. Studies evaluate new therapeutic agents aimed at improving metabolic health outcomes.

  • Diabetes Management
  • Lipid Disorders
  • Cardiovascular Risk Reduction

Innovative approaches being tested to address complex metabolic conditions and their complications.

03 Respiratory Medicine

Advanced research into treating Chronic Obstructive Pulmonary Disease, particularly focusing on patients with frequent exacerbations. Studies evaluate targeted biological therapies for respiratory conditions.

  • COPD Management
  • Exacerbation Prevention
  • Respiratory Function Improvement

Trials specifically designed to address severe respiratory conditions and improve patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.